Well Health - Digitale Services für die Medizin (Seite 4)

[winston-wolfe]

Antwort auf Beitrag Nr.: 75.494.775 von Chash-Carry am 21.03.24 14:43:09

Nein, Healwell ist mir zu Start-up, hat noch wenig Umsatz und macht keinen Gewinn. Lass die mal noch ein-zwei Jahre auf die Weide.
Ich hoffe Healwell wird ein weiteres erfolgreiches Puzzlestück in der Gesamtstory Well Health.

Healwell hat übrigens auch berichtet https://www.finanznachrichten.de/nachrichten-2024-03/6174544…

Zitat von Chash-Carry: Ja hab ich gesehen und gestern Abend hatte ich so ein Gefühl, da habe ich nochmal nachgelegt 😀 @Winston-wolfe hast du auch die well AI im de

[Chash-Carry]

Im Depot sollte das heißen!

[Chash-Carry]

Ja hab ich gesehen und gestern Abend hatte ich so ein Gefühl, da habe ich nochmal nachgelegt 😀 @Winston-wolfe hast du auch die well AI im de

[winston-wolfe]

Top Ergebnisse und weiteres Wachstum in 2024

WELL Health Reports Record Revenue, Adjusted EBITDA, and Net Income Results for Q4 and Full Year 2023 and Raises Revenue Guidance

https://www.wallstreet-online.de/nachricht/17912481-well-hea…

[Chash-Carry]

Hallo ist einer von euch auch bei der Well AI investiert? Die macht gerade noch mehr Spaß als die Well Health 😀

[winston-wolfe]

Antwort auf Beitrag Nr.: 75.341.768 von Chash-Carry am 25.02.24 17:06:47

Frag am besten w:o z.Th. Thread ...

Hamed Shahbazi, Founder, Chairman and CEO of WELL Health Technologies has been appointed Chairman of HEALWELL AI, a global leader in AI powered preventative care

Mr. Shahbazi’s appointment is strategically important for shareholders of both WELL and HEALWELL given the shared objective between the companies to create the most advanced and easy to use AI inspired tools that can equip care providers with various ‘Co-Pilots’ that can help them improve diagnosis of rare and chronic diseases, improve efficiency of their practice, and improve patient health outcomes.
WELL is currently the largest shareholder of HEALWELL with ownership of 20.7% of the company’s issued and outstanding voting securities. WELL also has an option to acquire approximately 30 million multi-voting shares that would give WELL a controlling position in HEALWELL, as defined on an IFRS financial reporting basis.
...
https://www.globenewswire.com/news-release/2024/02/27/283570…

Zitat von Chash-Carry: Moin der Investoren Kreis bei Well ist ja hier überschaubar. Was mich interessieren würde ist ob einer von euch bei Well AI investiert ist und was ihr von dem Ableger haltet? Was mich noch interessiert ist warum kann man bei WO kein Forum für Well AI eröffnen?? Wenn mir da jemand helfen könnte wäre ich dankbar. 😀 schönes Wochenende

[Chash-Carry]

Moin der Investoren Kreis bei Well ist ja hier überschaubar. Was mich interessieren würde ist ob einer von euch bei Well AI investiert ist und was ihr von dem Ableger haltet? Was mich noch interessiert ist warum kann man bei WO kein Forum für Well AI eröffnen?? Wenn mir da jemand helfen könnte wäre ich dankbar. 😀 schönes Wochenende

[winston-wolfe]

WELL Health wird "missverstanden" und ist unterbewertet, sagt RBC

Am 6. Februar begann Douglas Miehm, Analyst bei RBC Capital Markets, die Coverage von WELL mit einem "Outperform"-Rating und einem Kursziel von 5,50 US-Dollar, was zum Zeitpunkt der Veröffentlichung eine Rendite von 50 Prozent impliziert.

Der Analyst sagte, er denke, dass es derzeit eine Chance für Investoren gebe, da WELL Health "weitgehend missverstanden" werde.

"Wir starten bei WELL Health mit einem Outperform-Rating und einem Kursziel von 5,50 $", sagte Miehm. "Wir sehen WELL als ein komplexes, weitgehend missverstandenes Unternehmen und glauben, dass der Markt die langfristige wertschöpfende Chance bei der Transformation der CDN-Primär-/Dx-Versorgung unterschätzt, wie unsere starken prognostizierten ROIC- und IRR-Kennzahlen für die jüngsten Akquisitionen unterstreichen. In den USA sollte WELL von den Geschäftsbereichen mit hohem organischem Wachstum (20%+), Circle and Wisp und CRH mit hohen Margen profitieren. Da die Anleger beginnen, die potenziellen Chancen zu nutzen, die sich WELL bieten, glauben wir, dass die Aktie zulegen und die Konkurrenz übertreffen wird."
...
https://www.cantechletter.com/2024/02/well-health-is-misunde…

[winston-wolfe]

RBC Capital starts coverage on Well Health Technologies with Outperform rating

On Tuesday, RBC (TSX:RY) Capital initiated coverage on Well Health Technologies Corp. (WELL:CN) (OTC: WLYYF), assigning an Outperform rating with a price target of C$5.50. The firm recognizes Well Health as a multifaceted entity that is not fully understood by the market, suggesting that its long-term potential in transforming Canadian primary and diagnostic care is not fully appreciated.

According to RBC Capital, the company's recent acquisitions are expected to yield strong returns on invested capital (ROIC) and internal rates of return (IRR), indicating a positive outlook for the company's growth. The firm's analysis points to Well Health's opportunity to create value in a sector that is poised for transformation.
...
https://ca.investing.com/news/stock-market-news/rbc-capital-…

[winston-wolfe]

WELL Health Announces Record Patient Visits and Total Care Interactions for Q4-2023 and Projects Record Revenue and Positive EPS for the Quarter

WELL expects to announce positive EPS or Earnings Per Share on an adjusted and unadjusted basis for Q4-2023.1
WELL expects to announce its 20th consecutive quarter of record quarterly revenue in Q4-2023, underpinned by record care metrics which includes record patient visits of over 1.22 million and almost 1.87 million Total Care Interactions in the quarter with both metrics representing 18% sequential QoQ growth.2,3
This quarter's strong performance was driven by double-digit YoY organic growth as well as elevated inorganic growth in both US and Canadian patient visits. On a YoY basis, overall patient visits grew by 30% while Total Care Interactions grew by 38%.

WELL is proud to announce that its BC clinics which include some of the longest owned and operated clinics in the WELL family network have achieved a record Net Promoter Score (NPS) of 80% in Q4-2023 compared to industry average of 34% for the Canadian healthcare sector.4,5
VANCOUVER, BC and TORONTO, Jan. 25, 2024 /PRNewswire/ - WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) ("WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce positive preliminary quarterly financial results for Q4-2023 ending December 31, 2023 with projected record revenue and positive adjusted and non-adjusted EPS or Earnings per Share.1 WELL's strong financial performance was driven by another record quarter in patient visits which resulted in sequential QoQ growth of 18% and YoY growth of 30%.2

Hamed Shahbazi, Founder and CEO of WELL, commented "Based on our preliminary financial results and subject to finalizing our audit, I am extremely pleased to report that WELL expects to announce record revenues and Adjusted EBITDA including positive adjusted and unadjusted EPS for Q4 2023. As discussed in our business update last week, WELL's value proposition is resonating with the medical community across the country as the clear leader in helping clinic owners, administrators and care providers improve clinic operations. This is not only attracting an unprecedented number of new clinics and healthcare providers to WELL, but it is also giving us an opportunity to grow in an extremely capital efficient manner. Most of the clinics we add to our platform are profitable on day one and are handpicked because of the opportunity for margin and profit expansion. All of this is made possible due to our talented staff, extensive operating experience, and trusted technology platform now features powerful and responsible use of Artificial Intelligence."
...
https://www.finanznachrichten.de/nachrichten-2024-01/6123082…